Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Avanos Medical (AVNS) Return on Sales (2016 - 2025)

Avanos Medical's Return on Sales history spans 11 years, with the latest figure at 0.01% for Q4 2024.

  • For Q4 2024, Return on Sales fell 1.0% year-over-year to 0.01%; the TTM value through Dec 2024 reached 0.01%, up 7.0%, while the annual FY2023 figure was 0.08%, 12.0% down from the prior year.
  • Return on Sales for Q4 2024 was 0.01% at Avanos Medical, down from 0.01% in the prior quarter.
  • Across five years, Return on Sales topped out at 0.2% in Q2 2021 and bottomed at 0.72% in Q4 2021.
  • The 5-year median for Return on Sales is 0.01% (2023), against an average of 0.05%.
  • The largest annual shift saw Return on Sales soared 77bps in 2022 before it crashed -46bps in 2023.
  • A 5-year view of Return on Sales shows it stood at 0.26% in 2020, then tumbled by -171bps to 0.72% in 2021, then skyrocketed by 107bps to 0.05% in 2022, then plummeted by -106bps to 0.0% in 2023, then crashed by -275bps to 0.01% in 2024.
  • Per Business Quant, the three most recent readings for AVNS's Return on Sales are 0.01% (Q4 2024), 0.01% (Q3 2024), and 0.01% (Q2 2024).